Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Inmaculada Del Rincon

Contact

210-567-4662

delrincon@uthscsa.edu

Departments & Divisions

Inmaculada Del Rincon, M.D., M.Sc.

Professor of Medicine

Rheumatology specialist

Dr. del Rincon is a Professor of Medicine in the Division of Rheumatology and Clinical Immunology. She is certified in Rheumatology by the American Board of Internal Medicine and is a Fellow of the American College of Rheumatology. She sees patients with rheumatoid arthritis and other rheumatic diseases at the UT Health Physicians Medical Arts and Research Center and at the University Health System clinic downtown. In addition, she provides in-patient rheumatology consultations at the University Hospital.

Dr. del Rincon was born in Spain, where she grew up and obtained her medical education. She completed a Rheumatology Research Fellowship at UTHSCSA and obtained a Master of Science degree in Clinical Investigation at the Graduate School of Biomedical Sciences. Her award-wining research has focused on rheumatoid arthritis (RA) with special attention on the cardiovascular comorbidity that occurs in RA. She and her colleagues reported that the incidence of cardiovascular events in patients with RA is higher than that of people without RA, and that the increase is not due to a greater frequency of cardiovascular risk factors. Dr. del Rincon’s research has been funded by K23 and RO1 grants from the National Institutes of Health, and by the Arthritis Foundation and the American Heart Association. For her research, she has received awards from the American College of Rheumatology, the Arthritis Foundation and the American Heart Association. Dr. del Rincon has served on grant review panels from the NIH, the Arthritis Foundation and the VA, and on data safety and monitoring boards of multinational clinical trials.

  • Professional Background

    Education

    • 2004 - MS - Clinical Investigation - University of Texas Health Science Center
    • 1988 - MD - Medicine - Universidad Autonoma de Madrid
    • 1981 - BS - Chemistry and Biology (Summa Cum Laude) - Colegio La Salle Maravillas
    • Internship - Internal Medicine - Hospital Universitario Puerta de Hierro
    • Postdoctoral Fellowship - Health Services Research - Association of American Medical Colleges
    • Postdoctoral Fellowship - Rheumatology - University of Texas Health Science Center
    • Residency - Internal Medicine/Rheumatology - Hospital Universitario Puerta de Hierro

    Highlights

    03/2008

    R01 Grant Award, National Heart Lung and Blood Institute

    01/2002

    Arthritis Investigator Award, Arthritis Foundation

    01/2002

    American College of Rheumatology Matching Arthritis Investigator Award

    07/2001

    K23 Career Development Award, National Heart Lung and Blood Institute

    09/2000

    Fellow, Association of American Medical Colleges: Health Services Research Institute

    Appointments

    • 9/2013 - Professor of Medicine with Tenure - University of Texas Health Science Center, Medicine, San Antonio

  • Instruction & Training

    • 1/2005 - Present, Clinical Teaching, Rheumatology Clinic/University Health Center Downtown, University of Texas Health Science Center at San Antonio
    • 1/1997 - Present, Rheumatology Journal Club, University of Texas Health Science Center at San Antonio

  • Research & Grants

    Instrumentation - Non-invasive measurement of atherosclerosis and cardiovascular comorbidity.

    Research Methodology - Design, execution and analysis of cohort studies.

    Rheumatoid Arthritis - Patient oriented studies of outcome and prognosis.

    Grants

    Federal

    Funding Agency NIH (NIAMS) Title The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF Users Status Active Period 3/2016 - 2/2018 Role Co-Principal Investigator Grant Detail Clinical trial of the immunogenicity of the varicell-zoster vaccines (Zostavax) in patients with inflammatory arthritis who are receiving biologic therapy

    Private

    Funding Agency UCB Title A phase 3, randomized, double-blind, placebo controlled, multicenter study of the efficacy and safety of four 12 week treatment cycles (48 weeks total) of epratuzumab in SLE subjects with moderate to severe disease (EMBODY 2) Status Active Period 1/2012 - 1/2017 Role Co-Investigator Grant Detail The goal of this study is to test the efficacy and safety of epratuzumab, a humanized monoclonal antibody directed to the glycoprotein CD22 of mature and malignant B-cells, in subjects with moderate to severe systemic lupus erythematosus.

  • Publications

      Abstract

      Arya R, Del Rincon I, Restrepo JF, Farook VS, Jenkinson CP, Duggirala R, Escalante A. Cumulative Association of Genetic Variants with Rheumatoid Joint Damage Progression in Mexican Americans and European Americans; 2015 Oct. (Arthritis & Rheumatism; vol. 67, no. 10 Su). Restrepo JF, Del Rincon I, Escalante A. Joint Damage Associated with Loss of Body Mass in Rheumatoid Arthritis; 2015 Oct. (Arthritis & Rheumatology; vol. 67, no. 10 Su). Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A. Treatment Delays and Worse Outcomes Associated with Lower Socioeconomic Status in Rheumatoid Arthritis; 2014 Oct. (Arthritis & Rheumatism; vol. 66, no. 10 Su). Restrepo JF, Del Rincon I, Battafarano DF, Molina E, Escalante A. Use of Hydroxychloroquine Associated with Improved Lipid Profile in Rheumatoid Arthritis Patients; 2014 Oct. (Arthritis & Rheumatism; vol. 66, no. 10 Su). Arya R, Del Rincon I, Farook VS, Restrepo JF, Winnier, DA, Fourcadot MJ, Battafarano DF, Kumar S, de Almeida MAA, Curran JE, Jenkinson CP, Blangero J, Duggirala R, Escalante A. Genetic Variants Influencing Joint Damage in Mexican Americans and European Americans with Rheumatoid Arthritis; 2014 Oct. (Arthritis & Rheumatism; vol. 66, no. 10 Su). Molina, E, Restrepo, JF, Del Rincon I, Battafarano DF, Escalante A. Factors Associated with Recording of Rheumatoid Arthritis on Death Certificate; 2014 Oct. (Arthritis & Rheumatism; vol. 66, no. 10 Su). Restrepo JF, Del Rincon I, Haas RW, Battafarano DF, Escalante A. A Novel Index to Identify Interstitial Lung Disease in Rheumatoid Arthritis Patients; 2013 Oct. (Arthritis & Rheumatism; vol. 65, no. 10 Su). Del Rincon I, Haas RW, Restrepo JF, Battafarano DF, O'Leary DH, Molina E, Escalante A. Carotid Atherosclerosis As a Predictor Of Mortality In Rheumatoid Arthritis; 2013 Oct. (Arthritis & Rheumatism; vol. 65, no. 10 Su). del Rincon I, Sahai M, O`Leary DH, Battafarano DF, Escalante A. At what age is carotid ultrasound most effective in predicting cardiovascular events and mortality in rheumatoid arthritis; 2010 Oct. (Arthritis Rheum; vol. 62, no. 10 Su). Restrepo JF, del Rincon I, Zuniga-Montes LR, Pogosian S, Escalante A. Gene-environment interaction determines interstitial lung disease in rheumatoid arthritis; 2010 Oct. (Arthritis & Rheumatism; vol. 60, no. 10 Su).

      Journal Article

      Arya R, Del Rincon I, Farook VS, Restrepo JF, Winnier DA, Fourcaudot MJ, Battafarano DF, Kumar S, de Almeida MAA, Curran JE, Jenkinson CP, Blangero J, Duggirala R, and Escalante A. Genetic Variants Influencing Joint Damage in Mexican Americans and European Americans with Rheumatoid Arthritis Genetic Epidemiology 2015 Dec;39(8):678-688. Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A. Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates BMC Musculoskeletal Disorders 2015 Oct;16(277):1-6. Restrepo JF, Del Rincon I, Battafarano DF, Haas RW, Doria M, Escalante A. Clinical and Laboratory Factors Associated with Interstitial Lung Disease in Rheumatoid Arthritis Clinical Rheumatology 2015 Sep;34(9):1529-1536. Molina E, Del Rincon I, Restrepo JF, Battafarano DF, Escalante A. Association of socioeconomic status with treatment delays, disease activity, joint damage and disability in rheumatoid arthritis Arthritis Care & Research 2015 Jul;67(7):940-946. Del Rincon I, Polak JF, O`Leary DH, Battafarano DF, Erikson JM, Restrepo JF, Molina E, Escalante A. Systemic Inflammation and Cardiovascular Risk Factors Predict Rapid Progression of Atherosclerosis in Rheumatoid Arthritis Annals of the Rheumatic Diseases 2015 Jun;74(6):1118-1123. Molina E, Haas RW, Del Rincon I, Battafarano DF, Restrepo JF, Escalante A. Does the "Hispanic Paradox" apply to rheumatoid arthritis? Survival data from a multi-ethnic cohort Arthritis Care and Research 2014 Jul;66(7):972-979. Del Rincon I, Haas R, Battafarano D, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid Dose Thresholds Associated with All-cause and Cardiovascular Mortality in Rheumatoid Arthritis Arthritis and Rheumatology 2014 Feb;66(2):264-272.

  • Clinical

    Board Certifications

    • American Board of Internal Medicine/Rheumatology